NCT00255788View on ClinicalTrials.gov

Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

May 10, 2005

Primary Completion Date

July 22, 2008

Study Completion Date

January 18, 2011

Conditions
Breast Cancer
Interventions
DRUG

everolimus

Trial Locations (5)

V1Y 5L3

British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna

V3V 1Z2

Fraser Valley Cancer Centre at British Columbia Cancer Agency, Surrey

V5Z 4E6

British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver

L8V 5C2

Margaret and Charles Juravinski Cancer Centre, Hamilton

M4N 3M5

Toronto Sunnybrook Regional Cancer Centre at Sunnybrook and Women's College Health Sciences Centre, Toronto

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK